ERBB2 and triple-negative breast carcinoma: Based on the presence or absence of biomarkers for estrogen receptors, progesterone receptors and human epidermal growth factor 2 (HER2), BC can be categorized as luminal A/B, HER2-positive, or triple-negative breast cancer (TNBC) [2].